[Prospects in blood transfusion].
What will be the evolution of blood transfusion in the next 10 years? What are the scientific and medical arguments to help the decision makers to propose the developments? Many scientific and clinical studies show that blood substitutes are not ready for use in man. So, for a long time, blood collection in man will still be a necessity to prepare cell concentrates (red blood cells and platelets) and fresh frozen plasma. During this period, blood safety will be based on development of testing technics and preparation processes of blood products. Another major point will be a better clinical use of blood derivates. Cellular therapy will be probably only a way of diversification in blood transfusion centers in partnership with hospitals.
Rouger
P
P
Institut national de la transfusion sanguine, université Paris VI, Inserm U76, 6, rue Alexandre-Cabanel, 75015, Paris, France. prouger@ints.fr <prouger@ints.fr>
D001798:Blood Proteins / Q000302:isolation & purification / Q000627:therapeutic use; D001802:Blood Substitutes; D001803:Blood Transfusion / Q000639:trends*; D017848:Blood-Borne Pathogens / Q000302:isolation & purification; D016207:Cytokines / Q000097:blood; D017707:Erythrocyte Transfusion / Q000639:trends; D005544:Forecasting; D006801:Humans; D017713:Platelet Transfusion / Q000639:trends; D012106:Research / Q000639:trends; D018570:Risk Assessment; D012449:Safety; D065227:Transfusion Reaction
D001798:Blood Proteins; D001802:Blood Substitutes; D016207:Cytokines